MedTrace Logo

Clinical Performance of Hybrid Ceramic Laminate Veneers

NCT07027709 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2025-06-18

No results posted yet for this study

Summary

This randomized controlled trial evaluates the clinical performance of laminate veneers fabricated from HC hard blocks pretreated with BeautiBond Xtreme versus HC Primer, using BeautiLink SA cement. The study focuses on marginal adaptation, retention, discoloration, and recurrent caries over 18 months.

Conditions

  • Bonding of Veneers After Different Treatment

Interventions

DEVICE

BeautiBond Xtreme pretreatment with BeautiLink SA cementation

Laminate veneers fabricated from HC hard blocks were pretreated on the internal surface with BeautiBond Xtreme, then bonded to tooth structure using BeautiLink SA self-adhesive resin cement. The tooth surfaces were also treated with BeautiBond Xtreme. Veneers were digitally designed and milled, then cemented following a standardized clinical protocol.

PROCEDURE

HC Primer pretreatment with BeautiLink SA cementation

Laminate veneers fabricated from HC hard blocks were pretreated on the internal surface with HC Primer, then bonded to tooth structure using BeautiLink SA self-adhesive resin cement. The tooth surfaces were treated with BeautiBond Xtreme. Veneers were digitally designed and milled, then cemented following the same clinical protocol used in the experimental grou

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-12-01
Completion
2027-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07027709 on ClinicalTrials.gov